ArticleJCO precision oncology2020

Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.

Adem Albayrak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.